Jan 09th 2012 - Edison Investment Research today published a report on Allocate Software (ALL.L, LSE:ALL, LON:ALL) entitled "Healthy Start". In summary, the report says:
Allocate’s H1 trading update confirms a solid start to the year and expresses confidence in meeting full-year profit and revenue targets. Deal flow into the NHS continues, despite protracted sales cycles. Progress is also evident overseas, with a major deal with the Australian Defence Force and a national HealthRoster deal in Brunei. In the Maritime business, the signing of a third offshore oil and gas contract may prompt a more concerted drive to address this opportunity.
Edison Investment Research is a leading international investment research company. It has won industry recognition, with awards both in the UK and internationally. The team of 95 includes over 60 analysts supported by a department of supervisory analysts, editors and assistants. Edison writes on more than 400 companies across every sector and works directly with corporates, fund managers, investment banks, brokers and other advisers. Edison’s research is read by institutional investors, alternative funds and wealth managers in more than 100 countries. Edison, founded in 2003, has offices in London, New York and Sydney and is authorised and regulated by the Financial Services Authority (www.fsa.gov.uk/register/firmBasicDetails.do?sid=181584). more »